Syrma SGS Technology Limited (SYRMA)
Earning Call Transcript of the Investors Conference call held for the unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter ended June 30, 2026
AI summary
- Q1 FY27 consolidated revenue 1604 Cr +67% y-y; EBITDA 162 Cr +69% y-y; PAT 106 Cr +112% y-y
- Exports grew 61% in Q1, contributing 24% of revenue; expected 30-40% growth in FY27
- ODM sales doubled y-y to 270 Cr (17% of revenue), targeting 25% long-term share
- Order book at 6770 Cr with 35%+ revenue growth guidance for FY27
- Supply chain constraints persist; inventory treated as strategic asset to ensure supply
- PCB project on track for commercial production by April 2027; initial EBITDA 10%, asset turn 1-1.5x
- Automotive growth driven by EV and charging infrastructure; healthcare expected 50% growth
- New JV with Kaga India targets 300-500 Cr business over 3-5 years
- Management focused on long-term institution building, ESG initiatives, and cautious semiconductor entry
Source: Original filing PDF
—
view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts
BOT
🚨 SYRMA — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
📎 bseindia.com/xml-data/...
🎧 Audio summary ready
✓✓ 6:47 PM
Instant audio summaries2-min AI concall recap delivered with every earnings alert
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
Instant Telegram alertsResults, board meetings, insider trades — within minutes
Add SYRMA to your watchlist — all of this, automated.
Sign in with Google14-day Pro trial · No credit card · Cancel anytime
More on Syrma SGS Technology Limited
Important.
The summary above is generated automatically from Syrma SGS Technology Limited's own
public regulatory filing under SEBI LODR. Indian Stock Alerts is
not a SEBI-registered Research Analyst or Investment Adviser.
This page is informational, not investment advice, a recommendation to buy
or sell any security, or any opinion about the company's business, governance
or financial health. Always read the original filing before acting and consult
a registered adviser for investment decisions.